(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 29.3% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.11%.
Hyperfine's revenue in 2026 is $16,537,000.On average, 5 Wall Street analysts forecast HYPR's revenue for 2026 to be $2,181,102,975, with the lowest HYPR revenue forecast at $2,078,553,912, and the highest HYPR revenue forecast at $2,281,637,114. On average, 4 Wall Street analysts forecast HYPR's revenue for 2027 to be $2,844,861,595, with the lowest HYPR revenue forecast at $2,702,120,086, and the highest HYPR revenue forecast at $2,961,939,325.
In 2028, HYPR is forecast to generate $3,775,120,519 in revenue, with the lowest revenue forecast at $3,627,076,577 and the highest revenue forecast at $3,886,153,476.